Published in N Engl J Med on November 27, 2014
Understanding the pathogenesis of abdominal aortic aneurysms. Expert Rev Cardiovasc Ther (2015) 2.08
Mast cells in human and experimental cardiometabolic diseases. Nat Rev Cardiol (2015) 0.92
Novel Molecular Imaging Approaches to Abdominal Aortic Aneurysm Risk Stratification. Circ Cardiovasc Imaging (2016) 0.85
Diagnostic vascular ultrasonography with the help of color Doppler and contrast-enhanced ultrasonography. Ultrasonography (2016) 0.84
ePhenotyping for Abdominal Aortic Aneurysm in the Electronic Medical Records and Genomics (eMERGE) Network: Algorithm Development and Konstanz Information Miner Workflow. Int J Biomed Data Min (2015) 0.79
High Structural Stress and Presence of Intraluminal Thrombus Predict Abdominal Aortic Aneurysm 18F-FDG Uptake: Insights From Biomechanics. Circ Cardiovasc Imaging (2016) 0.78
Andrographolide Ameliorates Abdominal Aortic Aneurysm Progression by Inhibiting Inflammatory Cell Infiltration through Downregulation of Cytokine and Integrin Expression. J Pharmacol Exp Ther (2015) 0.76
Conversion from endovascular to open abdominal aortic aneurysm repair. J Vasc Surg (2016) 0.76
3D Printed Abdominal Aortic Aneurysm Phantom for Image Guided Surgical Planning with a Patient Specific Fenestrated Endovascular Graft System. Proc SPIE Int Soc Opt Eng (2017) 0.75
Inhibition of Receptor-Interacting Protein Kinase 1 with Necrostatin-1s ameliorates disease progression in elastase-induced mouse abdominal aortic aneurysm model. Sci Rep (2017) 0.75
Hybrid Endovascular Aortic Aneurysm Repair: Preservation of Pelvic Perfusion with External to Internal Iliac Artery Bypass. Ann Vasc Surg (2017) 0.75
Perioperative outcome of endovascular repair for complex abdominal aortic aneurysms. J Vasc Surg (2017) 0.75
A propensity score-matching analysis of transthoracic echocardiography and abdominal ultrasonography for the detection of abdominal aortic aneurysms. Clin Med Insights Cardiol (2015) 0.75
The Emerging Role of MicroRNA-155 in Cardiovascular Diseases. Biomed Res Int (2016) 0.75
The impact of concomitant procedures during endovascular abdominal aortic aneurysm repair on perioperative outcomes. J Vasc Surg (2016) 0.75
A Methodology for the Derivation of Unloaded Abdominal Aortic Aneurysm Geometry With Experimental Validation. J Biomech Eng (2016) 0.75
Sex-Related Differences Between Patients With Symptomatic Acute Aortic Dissection. Medicine (Baltimore) (2016) 0.75
Reversal of Vascular Calcification and Aneurysms in a Rat Model Using Dual Targeted Therapy with EDTA- and PGG-Loaded Nanoparticles. Theranostics (2016) 0.75
Role of molecular imaging with positron emission tomographic in aortic aneurysms. J Thorac Dis (2017) 0.75
Non-coding RNA Contribution to Thoracic and Abdominal Aortic Aneurysm Disease Development and Progression. Front Physiol (2017) 0.75
Aortic Wall Inflammation Predicts Abdominal Aortic Aneurysm Expansion, Rupture and Need for Surgical Repair. Circulation (2017) 0.75
Functional status predicts major complications and death after endovascular repair of abdominal aortic aneurysms. J Vasc Surg (2017) 0.75
Multi-modality molecular imaging of aortic aneurysms. J Nucl Cardiol (2017) 0.75
Reporting standards for endovascular aortic aneurysm repair. J Vasc Surg (2002) 3.35
Incidence and clinical significance of distal embolization during percutaneous interventions involving the superficial femoral artery. J Vasc Surg (2007) 2.55
Surgical treatment and outcomes of patients with primary inferior vena cava leiomyosarcoma. J Am Coll Surg (2003) 2.54
Recommended standards for reports dealing with arteriovenous hemodialysis accesses. J Vasc Surg (2002) 2.07
Effect of gender on long-term survival after abdominal aortic aneurysm repair based on results from the Medicare national database. J Vasc Surg (2011) 1.81
Guidelines for the reporting of renal artery revascularization in clinical trials. J Vasc Interv Radiol (2002) 1.75
Trends, complications, and mortality in peripheral vascular surgery. J Vasc Surg (2006) 1.72
Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. J Vasc Surg (2002) 1.64
Anti-receptor for advanced glycation end products therapies as novel treatment for abdominal aortic aneurysm. Ann Surg (2009) 1.60
Defining high-risk patients for endovascular aneurysm repair. J Vasc Surg (2009) 1.56
Gender trends in the repair of ruptured abdominal aortic aneurysms and outcomes. J Vasc Surg (2010) 1.54
Gadodiamide administration causes spurious hypocalcemia. Radiology (2003) 1.47
Causes and implications of readmission after abdominal aortic aneurysm repair. Ann Surg (2012) 1.39
TGF-beta through Smad3 signaling stimulates vascular smooth muscle cell proliferation and neointimal formation. Am J Physiol Heart Circ Physiol (2009) 1.36
Simulation improves resident performance in catheter-based intervention: results of a randomized, controlled study. Ann Surg (2006) 1.35
Transforming growth factor-beta promotes recruitment of bone marrow cells and bone marrow-derived mesenchymal stem cells through stimulation of MCP-1 production in vascular smooth muscle cells. J Biol Chem (2009) 1.33
Identifying and grading factors that modify the outcome of endovascular aortic aneurysm repair. J Vasc Surg (2002) 1.29
Isolated iliac artery aneurysms: a contemporary comparison of endovascular and open repair. J Vasc Surg (2008) 1.27
Protein kinase C delta induces apoptosis of vascular smooth muscle cells through induction of the tumor suppressor p53 by both p38-dependent and p38-independent mechanisms. J Biol Chem (2005) 1.22
Arterial gene transfer of the TGF-beta signalling protein Smad3 induces adaptive remodelling following angioplasty: a role for CTGF. Cardiovasc Res (2009) 1.20
Outcomes of endovascular treatment of ruptured abdominal aortic aneurysms. J Vasc Surg (2006) 1.20
PKCdelta is necessary for Smad3 expression and transforming growth factor beta-induced fibronectin synthesis in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2006) 1.16
Insurance status predicts access to care and outcomes of vascular disease. J Vasc Surg (2008) 1.15
Characterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery: Potential role of Smad3 in regulation of SMC proliferation. J Vasc Surg (2009) 1.15
Endovascular repair compared with surveillance for patients with small abdominal aortic aneurysms. J Vasc Surg (2010) 1.14
The impact of increasing age on anatomic factors affecting carotid angioplasty and stenting. J Vasc Surg (2007) 1.13
Guidelines for the reporting of renal artery revascularization in clinical trials. American Heart Association. Circulation (2002) 1.12
Understanding trends in inpatient surgical volume: vascular interventions, 1980-2000. J Vasc Surg (2004) 1.12
Shifting paradigms in the treatment of lower extremity vascular disease: a report of 1000 percutaneous interventions. Ann Surg (2007) 1.12
Stem cell factor and c-kit are expressed by and may affect vascular SMCs through an autocrine pathway. J Surg Res (2004) 1.11
TGF-β and restenosis revisited: a Smad link. J Surg Res (2011) 1.10
Computer simulation as a component of catheter-based training. J Vasc Surg (2004) 1.09
PDGF-BB regulates p27 expression through ERK-dependent RNA turn-over in vascular smooth muscle cells. J Biol Chem (2005) 1.07
Clinical competence statement on carotid stenting: training and credentialing for carotid stenting--multispecialty consensus recommendations: a report of the SCAI/SVMB/SVS Writing Committee to develop a clinical competence statement on carotid interventions. J Am Coll Cardiol (2005) 1.07
Contrast material travel times in patients undergoing peripheral MR angiography. Radiology (2002) 1.06
The cost-effectiveness of a "quick-screen" program for abdominal aortic aneurysms. Surgery (2002) 1.06
Management of endoleak after endovascular aneurysm repair: cuffs, coils, and conversion. J Vasc Surg (2003) 1.06
Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia. J Vasc Surg (2008) 1.05
A statewide experience with endovascular abdominal aortic aneurysm repair: rapid diffusion with excellent early results. J Vasc Surg (2004) 1.04
Caspase-mediated protein kinase C-delta cleavage is necessary for apoptosis of vascular smooth muscle cells. Am J Physiol Heart Circ Physiol (2009) 1.02
Protein kinase C-delta regulates migration and proliferation of vascular smooth muscle cells through the extracellular signal-regulated kinase 1/2. J Vasc Surg (2007) 1.01
Intimal hyperplasia--still here after all these years! Ann Vasc Surg (2004) 1.01
Endovascular treatment of traumatic carotid pseudoaneurysm with stenting and coil embolization. Ann Vasc Surg (2008) 1.01
Protein kinase C-delta mediates adventitial cell migration through regulation of monocyte chemoattractant protein-1 expression in a rat angioplasty model. Arterioscler Thromb Vasc Biol (2012) 1.00
Type I collagen synergistically enhances PDGF-induced smooth muscle cell proliferation through pp60src-dependent crosstalk between the alpha2beta1 integrin and PDGFbeta receptor. Biochem Biophys Res Commun (2004) 1.00
Multimodal therapy for acute and chronic venous thrombotic and occlusive disease. Vasc Endovascular Surg (2005) 0.99
The role of progenitor cells in the development of intimal hyperplasia. J Vasc Surg (2008) 0.98
The creation of an infrarenal aneurysm within the native abdominal aorta of swine. Surgery (2007) 0.97
Abdominal aortic aneurysm in women: prevalence, risk factors, and implications for screening. J Vasc Surg (2007) 0.96
Upregulation of protein kinase cdelta in vascular smooth muscle cells promotes inflammation in abdominal aortic aneurysm. J Surg Res (2008) 0.96
Is carotid angioplasty and stenting more cost effective than carotid endarterectomy? J Vasc Surg (2003) 0.95
Carotid angioplasty and stent-induced bradycardia and hypotension: Impact of prophylactic atropine administration and prior carotid endarterectomy. J Vasc Surg (2005) 0.95
Transforming growth factor-β increases vascular smooth muscle cell proliferation through the Smad3 and extracellular signal-regulated kinase mitogen-activated protein kinases pathways. J Vasc Surg (2012) 0.95
Biodegradable arginine-based poly(ester-amide)s as non-viral gene delivery reagents. Biomaterials (2008) 0.94
Endovascular aneurysm repair--is it durable? N Engl J Med (2010) 0.94
The signaling protein Rho is necessary for vascular smooth muscle migration and survival but not for proliferation. Surgery (2002) 0.94
Preferential secretion of collagen type 3 versus type 1 from adventitial fibroblasts stimulated by TGF-β/Smad3-treated medial smooth muscle cells. Cell Signal (2012) 0.93
Current management of extracranial carotid artery disease. Vasc Endovascular Surg (2006) 0.93
Analysis of anatomic factors and age in patients undergoing carotid angioplasty and stenting. Ann Vasc Surg (2005) 0.93
Guidelines for the reporting of renal artery revascularization in clinical trials. J Vasc Interv Radiol (2003) 0.92
Rapamycin inhibits fibronectin-induced migration of the human arterial smooth muscle line (E47) through the mammalian target of rapamycin. Am J Physiol Heart Circ Physiol (2005) 0.92
TGF-beta stimulates collagen (I) in vascular smooth muscle cells via a short element in the proximal collagen promoter. J Surg Res (2003) 0.92
Local drug delivery to prevent restenosis. J Vasc Surg (2013) 0.92
National trends in the repair of ruptured abdominal aortic aneurysms. J Vasc Surg (2008) 0.92
TGF-β and Smad3 modulate PI3K/Akt signaling pathway in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol (2012) 0.91
Superficial femoral artery occlusive disease severity correlates with MR cine phase-contrast flow measurements. J Magn Reson Imaging (2006) 0.91
The novel function of advanced glycation end products in regulation of MMP-9 production. J Surg Res (2010) 0.91
Phosphorylation of the cyclic AMP response element binding protein mediates transforming growth factor beta-induced downregulation of cyclin A in vascular smooth muscle cells. Mol Cell Biol (2007) 0.90
Analysis of outcomes following failed endovascular treatment of chronic limb ischemia. Ann Vasc Surg (2006) 0.90
Minimally invasive retrieval of a dislodged Wallstent endoprosthesis after an endovascular abdominal aortic aneurysm repair. J Vasc Surg (2008) 0.90
Novel treatment of patients with lower extremity ischemia: use of percutaneous atherectomy in 579 lesions. Ann Surg (2008) 0.89
Outcomes of carotid stenting compared with endarterectomy are equivalent in asymptomatic patients and inferior in symptomatic patients. J Vasc Surg (2010) 0.89
Treatment of type II endoleaks with a novel polyurethane thrombogenic foam: induction of endoleak thrombosis and elimination of intra-aneurysmal pressure in the canine model. J Vasc Surg (2005) 0.89
Comparison of results in endovascular interventions for infrainguinal lesions: claudication versus critical limb ischemia. Am Surg (2005) 0.88
Is there a relationship between patient satisfaction and favorable outcomes? Ann Surg (2014) 0.88
Accelerated aneurysmal dilation associated with apoptosis and inflammation in a newly developed calcium phosphate rodent abdominal aortic aneurysm model. J Vasc Surg (2012) 0.88
Analysis of parameters associated with hypotension requiring vasopressor support after carotid angioplasty and stenting. J Vasc Surg (2006) 0.88
Bolus arterial-venous transit in the lower extremity and venous contamination in bolus chase three-dimensional magnetic resonance angiography. Invest Radiol (2002) 0.87
Arterial vascular disease in women. J Vasc Surg (2007) 0.87
Randomized trials in surgery. Surgery (2009) 0.87
Protein kinase C delta activated adhesion regulates vascular smooth muscle cell migration. J Surg Res (2007) 0.86
Endoluminal recanalization in a patient with phlegmasia cerulea dolens using a multimodality approach. Vascular (2005) 0.86
Comparison of surgical operative experience of trainees and practicing vascular surgeons: a report from the Vascular Surgery Board of the American Board of Surgery. J Vasc Surg (2010) 0.86
Protein kinase C-δ (PKCδ) regulates proinflammatory chemokine expression through cytosolic interaction with the NF-κB subunit p65 in vascular smooth muscle cells. J Biol Chem (2014) 0.85
Development of a novel scoring tool for the identification of large ≥5 cm abdominal aortic aneurysms. Ann Surg (2010) 0.85
Gene expression analysis of a porcine native abdominal aortic aneurysm model. Surgery (2008) 0.85
Ischemic preconditioning during the use of the PercuSurge occlusion balloon for carotid angioplasty and stenting. Vascular (2008) 0.85
Abdominal aortic aneurysm causing duodenal obstruction: two case reports and review of the literature. J Vasc Surg (2004) 0.85
Why insurers should reimburse for compression stockings in patients with chronic venous stasis. J Vasc Surg (2002) 0.85
Percutaneous endovascular treatment for chronic limb ischemia. Ann Vasc Surg (2005) 0.84
Aortoiliac occlusive disease in patients with known or suspected peripheral vascular disease: safety and efficacy of gadofosveset-enhanced MR angiography--multicenter comparative phase III study. Radiology (2005) 0.84
Filter devices for cerebral protection during carotid angioplasty and stenting. J Endovasc Ther (2003) 0.84
Resection of an intravenous leiomyoma with intracardiac extension with use of endovascular techniques. J Vasc Surg (2004) 0.84
Decreased venous contamination on 3D gadolinium-enhanced bolus chase peripheral mr angiography using thigh compression. AJR Am J Roentgenol (2004) 0.83
Infrainguinal occlusive disease: endovascular intervention is the first line therapy. Adv Surg (2008) 0.83
Use of cine magnetic resonance angiography in quantifying aneurysm pulsatility associated with endoleak. J Vasc Surg (2003) 0.83
Management strategy for compartment syndrome of the upper extremity arising during anticoagulation or thrombolytic therapy: an increasingly common surgical dilemma. Ann Plast Surg (2003) 0.83